Valuation MannKind Corporation

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 17/04/2026 BST			5-day change	1st Jan Change
2.840 ^USD	+3.27%		+10.51%	-49.91%

03-11	MannKind Corporation Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 01:00 PM
03-09	MannKind Corporation to Present New Data from Pediatric and Adult Studies of Afrezza at ATTD 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	1,098	1,387	981.3	1,773	1,741	877	-	-
Change	-	26.33%	-29.26%	80.71%	-1.81%	-49.63%	-	-
Enterprise Value (EV)	1,098	1,387	679	1,773	1,741	877	877	877
Change	-	26.33%	-51.05%	161.16%	-1.81%	-49.63%	0%	0%
P/E ratio	-13.7x	-15.5x	-91x	64.3x	284x	-151x	26.4x	21.4x
PBR	-	-	-	-	-	-	-	-
PEG	-	-2.48x	1x	-0x	-3.6x	1x	-0x	0.9x
Capitalization / Revenue	14.6x	13.9x	4.93x	6.21x	4.99x	1.88x	1.67x	1.61x
EV / Revenue	0x	0x	0x	0x	0x	1.88x	1.67x	1.61x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	0x	0x	0x	18.6x	9.87x	8.93x
EV / FCF	-	-	-0x	0x	0x	20.9x	10.1x	22.5x
FCF Yield	-	-	-0.85%	1.85%	0.79%	4.79%	9.92%	4.45%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.32	-0.34	-0.04	0.1	0.02	-0.0188	0.1075	0.1329
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	75.44	99.77	199	285.5	349	465.9	524.3	544.8
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-47.02	-64.11	8.678	72.59	38.8	47.19	88.88	98.2
Net income ¹	-80.93	-87.4	-11.94	27.59	5.863	-1.843	47.81	62.04
Net Debt	-	-	-302.3	-	-	-	-	-
Reference price ²	4.370	5.270	3.640	6.430	5.670	2.840	2.840	2.840
Nbr of stocks (in thousands)	251,256	263,196	269,575	275,778	307,070	308,796	-	-
Announcement Date	24/02/22	23/02/23	27/02/24	26/02/25	26/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MANNKIND CORPORATION	-151.47x	-	-	-	877M
ARGENX SE	29.65x	7.87x	23.41x	0.05%	52.7B
WUXI APPTEC CO., LTD.	17.06x	5.13x	11.65x	1.73%	44.07B
INSMED INCORPORATED	-56.08x	17.84x	-60.31x	-.--%	31.19B
BIONTECH SE	-19.28x	4.64x	-9.17x	-.--%	26.03B
SUMMIT THERAPEUTICS INC.	-20.14x	2414.99x	-28.03x	-.--%	19.5B
WUXI BIOLOGICS (CAYMAN) INC.	28.36x	5.54x	15.41x	-.--%	18.88B
AKESO, INC.	-429.08x	35.92x	4520.31x	-.--%	17.76B
GENMAB A/S	23.57x	4.08x	12.46x	-.--%	17.49B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-522.78x	37.79x	-954.84x	-.--%	15.49B
Average	-110.02x	281.53x	392.32x	0.2%	24.4B
Weighted average by Cap.	-62.43x	204.89x	267.80x	0.32%